“These results demonstrate that combination treatment with EGCG and dacarbazine strongly inhibits melanoma growth and metastasis, and the action mechanisms of EGCG are associated with the inhibition of cell spreading, cell‐extracellular matrix and cell‐cell interactions, MMP‐9 and FAK activities.”